In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, predicts Roots Analysis
With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced solutions.   Roots Analysis is pleased to announce the publication of its recent study, titled, “In Vitro ADME Testing...
0 Comments 0 Shares